Exciting Times Ahead: Welcoming Our New CEO and Unveiling Our Grant Program
In our July Newsletter, we announce the appointment of a new Chief Executive Officer (CEO) who is set to lead our organization into a promising future. Alongside this exciting development, we unveil our latest initiative, a groundbreaking grant program that aims to propel innovation and drive groundbreaking discovery.
Introducing Our Visionary New CEO
With a firm belief in the power of exceptional leadership, we welcome Mr. Christophe Valat as the new CEO of Firalis Molecular Precision. Boasting an illustrious career and remarkable accomplishments within the pharma and biotech industry, Mr. Valat brings a wealth of experience and a transformative vision to the helm.
FMP x Vizgen Grant Program: Fueling Innovations
Designed to ignite innovation and address pressing challenges in our industry, the Grant Program we have launched will serve as a catalyst for change and a platform for the realization of groundbreaking ideas.
Through this program, we offer a chance to EU scientists and researchers to access Vizgen’s MERSCOPE® Platform for single-cell spatial analysis, leveraging the PanCancer Pathways (Human) or PanNeuro Cell Type (Mouse) Predesigned Gene Panels, and comprehensive data analysis services provided by our skilled bioinformatics team. Learn more about the Grant Program and apply today !
